541 related articles for article (PubMed ID: 2417744)
1. Pharmacology of the bipyridines: amrinone and milrinone.
Alousi AA; Johnson DC
Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
[TBL] [Abstract][Full Text] [Related]
2. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
Endoh M; Yanagisawa T; Taira N; Blinks JR
Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
[TBL] [Abstract][Full Text] [Related]
3. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle.
Binah O; Sodowick B; Vulliemoz Y; Danilo P; Rosen M
Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle.
Silver PJ; Harris AL; Canniff PC; Lepore RE; Bentley RG; Hamel LT; Evans DB
J Cardiovasc Pharmacol; 1989 Apr; 13(4):530-40. PubMed ID: 2470989
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
Hayes JS; Bowling N; Boder GB; Kauffman R
J Pharmacol Exp Ther; 1984 Jul; 230(1):124-32. PubMed ID: 6086873
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase-inhibiting properties of newer inotropic agents.
Scholz H; Meyer W
Circulation; 1986 Mar; 73(3 Pt 2):III99-108. PubMed ID: 2417748
[TBL] [Abstract][Full Text] [Related]
7. Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle.
Sys SU; Goenen MJ; Chalant CH; Brutsaert DL
Circulation; 1986 Mar; 73(3 Pt 2):III25-35. PubMed ID: 3002662
[TBL] [Abstract][Full Text] [Related]
8. Effects of amrinone and milrinone on calcium influx into the myocardium.
Sutko JL; Kenyon JL; Reeves JP
Circulation; 1986 Mar; 73(3 Pt 2):III52-8. PubMed ID: 3002664
[TBL] [Abstract][Full Text] [Related]
9. In-vivo effects of amrinone and milrinone on left ventricular dP/dt, intraventricular pressure and heart rate in pentobarbital-anesthetized guinea pigs.
Lin BB; Chen HL
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):237-40. PubMed ID: 1811284
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T
Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308
[TBL] [Abstract][Full Text] [Related]
11. Enhanced relaxation and reduced positive inotropic effects of amrinone in ventricular muscle from cats with subacute heart failure. Implications for drug therapy.
Bassett AL; Gaide MS; Lodge NJ; Cameron JS
Adv Myocardiol; 1985; 6():629-36. PubMed ID: 2986264
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the cardiotonic effects of milrinone, a new and potent cardiac bipyridine, on isolated tissues from several animal species.
Alousi AA; Stankus GP; Stuart JC; Walton LH
J Cardiovasc Pharmacol; 1983; 5(5):804-11. PubMed ID: 6195468
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
[TBL] [Abstract][Full Text] [Related]
14. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog.
Lebedinsky Y; Nordstrom ST; Aschoff SE; Kapples JF; O'Malley GJ; Kosley RW; Fielding S; Hubbard JW
J Cardiovasc Pharmacol; 1992 May; 19(5):779-89. PubMed ID: 1381777
[TBL] [Abstract][Full Text] [Related]
15. [Milrinone decreases the positive inotropic response of heart muscle to izadrin].
Bardamova IB; Afanas'ev SA
Eksp Klin Farmakol; 1994; 57(4):29-31. PubMed ID: 7950778
[TBL] [Abstract][Full Text] [Related]
16. Positive inotropic and chronotropic effects of toborinone and its electrophysiological properties in the isolated hearts of rabbits and guinea-pigs.
Takase H; Orito K; Mori T; Fujiki H; Sekiguchi K; Tominaga M; Iijima T
Arzneimittelforschung; 1996 Jun; 46(6):579-86. PubMed ID: 8767347
[TBL] [Abstract][Full Text] [Related]
17. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
Ahn HS; Eardley D; Watkins R; Prioli N
Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728
[TBL] [Abstract][Full Text] [Related]
18. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
Endoh M; Yamashita S; Taira N
J Pharmacol Exp Ther; 1982 Jun; 221(3):775-83. PubMed ID: 6283063
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic response and effects on myocardial energetics of 3-cyano-2-morpholino-5-(pyrid-4-yl)pyridine (AWD 122-14) in anesthetized minipigs.
Rohde E; Wiesner B; Muschick P
Pharmazie; 1993 Sep; 48(9):690-4. PubMed ID: 8234405
[TBL] [Abstract][Full Text] [Related]
20. In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor.
Wilhelm D; Wilffert B; Janssens WJ; Leidig A; Meuter C; Ebbert M; Peters T
J Cardiovasc Pharmacol; 1992; 20(5):705-14. PubMed ID: 1280731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
